Neurodegenerative Diseases News and Research

RSS

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson's disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.

15 Mar 2024

Study highlights growing burden of neurological disorders worldwide

Globally, the number of people living with, or dying from, neurological conditions such as stroke, Alzheimer's disease and other dementias, and meningitis has risen substantially over the past 30 years due to the growth and aging of the global population as well as increased exposure to environmental, metabolic, and lifestyle risk factors.

15 Mar 2024

Microfluidic chips advance neurodegenerative disease research

Researchers review the role of microfluidic chip models in understanding neurodegenerative diseases, offering insights into the disease mechanisms and potential for drug development through innovative lab-on-a-chip technologies.

14 Mar 2024

Researchers shed light on cancer cell survival in early hypoxia

Researchers at the Francis Crick Institute have shed light on how cancer cells survive in the first few hours after being cut off from a supply of oxygen.

14 Mar 2024

Groundbreaking study unveils new insights into neurodegenerative disorder symptoms

Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing.

14 Mar 2024

Study highlights potential of p-tau217 assays in Alzheimer's clinical trials and diagnosis

The performance of two commercial phospho-tau217 (p-tau217) assays.

14 Mar 2024

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

Defects in the blood vessel network of the central nervous system have been linked to early symptoms of neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis (ALS).

13 Mar 2024

Exploring the power of diet: A new frontier in disease management and cancer treatment

The therapeutic potential of and molecular mechanisms through which dietary interventions impact a wide range of human diseases.

13 Mar 2024

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

Researchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.

11 Mar 2024

PFAS chemicals in the blood are linked with increased risk of cardiovascular diseases

Researchers at DZNE provide evidence that traces of the widely used PFAS chemicals in human blood are associated with unfavorable lipid profiles and thus with an increased risk of cardiovascular diseases.

11 Mar 2024

Eight voices of progress: AZoNetwork #InspireInclusion for International Women's Day 2024

Each year on March 8th, International Women's Day (IWD) shines a spotlight on the monumental achievements of women around the globe. For 2024, the theme #InspireInclusion invites us to embrace diversity and champion the inclusion of women in all spheres of life.

8 Mar 2024

Breakthrough in CRISPR delivery promises safer gene editing

Recent research in PNAS highlights advancements in non-viral, cell-specific delivery methods for CRISPR-Cas systems, emphasizing their potential to enhance research and gene therapy applications by minimizing risks associated with off-target effects and improving targeted delivery.

7 Mar 2024

Unraveling typical disease trajectories in multimorbid patients from birth to death

In a recent study published in npj Digital Medicine, Complexity Science Hub researchers analyzed a comprehensive dataset of 44 million hospital stays in Austria.

7 Mar 2024

Human molecular adaptations to fasting: Insights from proteomic analysis

Researchers investigate systemic proteome adaptations to one week of fasting in humans.

6 Mar 2024

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease (AD) and other neurodegenerative diseases, today announces a new epigenetics collaboration with Sheffield Hallam University.

4 Mar 2024

UW researchers find similarities between diabetes and Alzheimer's protein clusters

Of the 38 million Americans who have diabetes at least 90% have Type 2, according to the Centers for Disease Control and Prevention.

29 Feb 2024

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions.

From PharmaKure 29 Feb 2024

UCLA researchers uncover dual role of GAN gene in neurological disorder, head and neck cancer

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center show for the first time that a gene usually linked to giant axonal neuropathy, a rare and severe neurological condition, also plays a role in inhibiting aggressive tumor cell growth in head and neck cancers.

29 Feb 2024

Brain waves drive waste removal during sleep, study finds

There lies a paradox in sleep. Its apparent tranquility juxtaposes with the brain's bustling activity. The night is still, but the brain is far from dormant.

28 Feb 2024

Novel "Tissue-in-a-CUBE" model mimics blood-brain barrier for drug testing

A research team at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan has succeeded in establishing a model of the blood-brain barrier using modularized tissue derived from human cells.

28 Feb 2024

Neurodegenerative Diseases News and Research

Innovative levodopa infusion pump trial shows promise for reducing Parkinson's symptoms

Study highlights growing burden of neurological disorders worldwide

Microfluidic chips advance neurodegenerative disease research

Researchers shed light on cancer cell survival in early hypoxia

Groundbreaking study unveils new insights into neurodegenerative disorder symptoms

Study highlights potential of p-tau217 assays in Alzheimer's clinical trials and diagnosis

Study reveals TDP-43 protein's key role in blood vessel formation and integrity

Exploring the power of diet: A new frontier in disease management and cancer treatment

Research highlights the need for continued surveillance of emerging SARS-CoV-2 variants and vaccines

PFAS chemicals in the blood are linked with increased risk of cardiovascular diseases

Eight voices of progress: AZoNetwork #InspireInclusion for International Women's Day 2024

Breakthrough in CRISPR delivery promises safer gene editing

Unraveling typical disease trajectories in multimorbid patients from birth to death

Human molecular adaptations to fasting: Insights from proteomic analysis

PharmaKure partners with Sheffield Hallam University to develop epigenetic markers for Alzheimer’s disease prediction

UW researchers find similarities between diabetes and Alzheimer's protein clusters

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

UCLA researchers uncover dual role of GAN gene in neurological disorder, head and neck cancer

Brain waves drive waste removal during sleep, study finds

Novel "Tissue-in-a-CUBE" model mimics blood-brain barrier for drug testing

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News